Novo Nordisk’s Weight Loss Injections for Diabetics Show Promising Results

Novo Nordisk has developed weight loss injections for diabetics that have also been found to promote significant weight loss. These injections mimic a hormone called GLP1, which helps regulate blood sugar levels and promotes weight loss.

The first injection, Saxenda, led to an 8% loss of body weight. Subsequent injections, Ozempic and Vigobi, were even more effective for weight loss. The injections work by increasing insulin secretion, decreasing glucagon secretion, slowing down stomach emptying, and suppressing appetite by affecting the hunger center in the brain.

Vigobi is taken gradually with a dosage of 2.4 milligrams to reduce side effects. The injections will be available in pharmacies and prescribed by private doctors at a cost ranging from NIS 600 to NIS 1,250 depending on the dosage. Treatment with these injections can continue as long as necessary and may be stopped at any time.

While these injections can help with weight loss, a healthy lifestyle including proper nutrition and exercise is crucial for long-term success. Common side effects include bloating, nausea, vomiting, diarrhea, and changes in food preferences. Despite this, the injections are considered safe for most patients and have been shown to reduce the risk of heart attacks and strokes.

It’s important to note that while these injections can be an effective tool for weight loss, they should not be used as a replacement for a healthy diet and exercise regimen. Consulting with a healthcare professional before starting any new treatment or medication is recommended to ensure safety and effectiveness.